- Products
- Catalogs
- News & Trends
- Exhibitions
COVID-19 rapid diagnostic test Gmate®for neutralizing antibodyserumplasma
Add to favorites
Compare this product
Characteristics
- Applications
- COVID-19
- Tested parameter
- for neutralizing antibody
- Sample type
- serum, plasma, whole blood
- Result display time
15 min
- Specificity
98.5 %, 99.3 %
- Sensitivity
95.2 %, 97.6 %
Description
Gmate® COVID 19 Total antibody / neutralizing antibody is an in vitro diagnostic medical device that qualitatively detects neutralizing antibodies to COVID-19 in patient's blood by immunochromatography
Performance
Accuracy: 98.31%
Accuracy: 98.31%
Related Searches
- Blood rapid diagnostic test
- Rapid lateral flow test
- Immunoassay rapid diagnostic test
- Rapid virus test
- Serum rapid diagnostic test
- Plasma rapid diagnostic test
- Whole blood rapid diagnostic test
- Rapid respiratory infection test
- COVID-19 rapid diagnostic test
- POC reader
- Nasopharyngeal rapid diagnostic test
- Rapid oral flu test
- POC reader with touchscreen
- Optical POC analyzer
- Cell rapid diagnostic test
- Antigen POC reader
- POC virus analyzer
- Respiratory disease POC analyzer
- Immunity rapid diagnostic test
- Neutralizing antibody rapid test
*Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.